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Background. The biggest challenge in human immunodeficiency virus type 1 (HIV-1) prevention in Africa is
the high HIV-1 burden in young women. In macaques, proinflammatory cytokine production in the genital tract is
necessary for target cell recruitment and establishment of simian immunodeficiency virus (SIV) infection following
vaginal inoculation. The purpose of this study was to assess if genital inflammation during early HIV-1 infection
predisposes women to rapid disease progression.
Methods. Inflammatory cytokine concentrations were measured in cervicovaginal lavage (CVL) from 49 women
6, 17, 30, and 55 weeks after HIV-1 infection and from 22 of these women before infection. Associations between
genital inflammation and viral load set point and blood CD4 cell counts 12 months after infection were investigated.
Results. Elevated genital cytokine concentrations 6 and 17 weeks after HIV-1 infection were associated with
higher viral load set points and, to a lesser extent, with CD4 depletion. CVL cytokine concentrations during early
infection did not differ relative to preinfection but were elevated in women who had vaginal discharge, detectable
HIV-1 RNA in their genital tracts, and lower blood CD4 counts.
Conclusion. Genital inflammation during early HIV-1 infection was associated with higher viral load set point
and CD4 depletion, which are markers of rapid disease progression. Strategies aimed at reducing genital
inflammation during early HIV-1 infection may slow disease progression.
In sub-Saharan Africa, which has the highest prevalence
of human immunodeficiency virus type 1 (HIV-1)
worldwide, most new infections occur by sexual trans-
mission to women [1]. The genital mucosa is the initial
site of viral replication following vaginal transmission of
HIV-1 in women and simian immunodeficiency virus
(SIV) in rhesus macaques [2, 3]. In macaques, vaginal
inoculation with SIV is followed by proinflammatory
cytokine production and recruitment of CD41 T cells
that are necessary for local viral expansion and dis-
semination to the systemic compartment [4–6]. Proin-
flammatory cytokine expression in the genital mucosa
correlates with viral replication and approaches baseline
as peak SIV viremia declines [6]. HIV-1 infection may
likewise be accompanied by an early inflammatory cas-
cade in the genital tract that is associated with viral
replication in this compartment. HIV-1 has been shown
to directly induce inflammatory cytokine production
via Toll-like receptor 7 and 8 activation [7]. Elevated
concentrations of inflammatory cytokines in turn may
upregulate HIV-1 replication by recruiting and activat-
ing target cells and through NF-jB activation [4, 8–11].
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Several studies have shown that cervicovaginal proin-
flammatory cytokines are upregulated in women with early or
chronic HIV-1 infection compared with HIV-uninfected
women [10, 12–16]. However this upregulation may be attrib-
uted to the high frequency of sexually transmitted infections
(STIs) or bacterial vaginosis (BV) in these individuals rather
than HIV-1 itself [17]. For example, BV was associated with
increased concentrations of proinflammatory interleukin
(IL)–1b, whereas chronic HIV-1 infection was not [18].
HIV-1 shedding, which is associated with STIs [19], may
induce further inflammatory cytokine production.
Plasma cytokine concentrations during early HIV-1 infection
are predictive of plasma viral load set points and CD4 depletion
[20], and treatment with cytokines such as IL-12p70 and IL-15
during acute SIV infection is associated with altered disease
course in macaques [21–23]. Several studies have suggested that
cytokine responses in the genital tract during the early stages
of HIV-1 infection may likewise be associated with disease
progression. In macaques, induction of inflammatory cytokines
and immune cell influx into the genital tract prior to vaginal SIV
inoculation was associated with increased plasma viral load set
points [24]. This suggests that preexisting genital inflammation
in humans may similarly influence HIV-1 disease progression.
Zara et al [14] demonstrated that upregulation of IL-1b in the
genital tracts of HIV-1–infected women was associated with
increased plasma viral loads. Recently, we reported that elevated
proinflammatory cytokines in cervicovaginal lavage (CVL) cor-
related with lower blood CD41 T-cell counts during early HIV-1
infection [15].
In this study, the relationships between genital cytokine
concentrations during early HIV-1 infection and plasma viral




Forty-nine South African women recently infected with HIV-1
subtype C were recruited as part of the CAPRISA Acute Infection
Study [25]. Each woman provided informed consent and then
attended regular evaluations of HIV-1 disease status. Time of
infection was defined as the midpoint between the last HIV-1
antibody negative test result and the first HIV-1 antibody posi-
tive test result, or as 14 days prior to a positive RNA polymerase
chain reaction (PCR) assay on the same day as a negative HIV-1
enzyme immunoassay. This study was approved by the Uni-
versity of Kwazulu-Natal and University of Cape Town ethics
committees.
Cytokine Measurements
CVL samples were collected, as described elsewhere [15], at
5 time points: 22 women were assessed preinfection (36 weeks
preinfection, range, 2–92), 39 were assessed 6 weeks postinfection
(range, 1–13), 32 were assessed at 17 weeks postinfection (range,
14–23), 39 were assessed at 30 weeks postinfection (range,
24–36), and 40 were assessed at 55 weeks postinfection
(range, 50–62). Eighteen of the 22 women who were assessed
preinfection had matching 6-week postinfection CVL sam-
ples available. CVLs were prefiltered using 0.2 lm Costar
Spin-X cellulose acetate filters (Sigma) and the supernatant
was stored at 280C. Concentrations of IL-1a, IL-1b, IL-2,
IL-6, IL-7, IL-8, IL-10, IL-12p40, IL-12p70, IL-15, interferon
(IFN)–a, eotaxin, fractalkine, granulocyte colony-stimulating
factor (G-CSF), granulocyte macrophage (GM)–CSF, mono-
cyte chemotactic protein 1, macrophage inflammatory protein
(MIP)–1a, MIP-1b, MIP-3a, RANTES, soluble CD40 ligand
(sCD40L), and tumor necrosis factor (TNF)–a were measured
using Human Cytokine LINCOplex premixed kits (LINCO
Research), Milliplex kits (Millipore), and enzyme-linked im-
munosorbent assay (R&D Systems). The sensitivity of these kits
ranged between 0.05 and 18.33 pg/mL. Multiplex data were
collected using a Bio-Plex Suspension Array Reader (Bio-Rad
Laboratories), and a 5 PL regression formula was used to calculate
cytokine concentrations from the standard curves (Bio-Plex
Manager software, version 4). Cytokine concentrations below the
lower limit of detection were reported as the midpoint between
the lowest concentration measured for each cytokine and zero.
Clinical Characteristics
Blood was collected by venipuncture into acetate citrate dextran
vacutainer tubes. Absolute blood CD41 T-cell counts were mea-
sured using a FACSCalibur flow cytometer. Plasma HIV-1 RNA
concentrations were quantified using the COBAS AMPLICOR
HIV-1Monitor v1.5 or COBAS Ampliprep/COBAS TaqMan 48
Analyzer (Roche Diagnostics). CVL viral loads were determined
using Nuclisens Easyq HIV-1 (version 1.2). As viral load set
point after 3 months postinfection is predictive of time to AIDS
[26], the average viral load measurement of 3 consecutive visits
overlying 12 months postinfection (range, 37–69) was used to
assess disease progression. Additionally, associations between
cytokines and (1) average CD41 T-cell measurements of the
same 3 visits and (2) CD41 T-cell loss between preinfection and
12 months postinfection were investigated.
Participants were screened for Chlamydia trachomatis,Neisseria
gonorrhoeae, and herpes simplex virus type 2 (HSV-2) in cervical
swab samples by PCR and Trichomonas vaginalis by Diamond’s
culture and PCR. Agents of BV were assessed by Gram staining.
Statistical Analyses
Statistical analyses were performed using GraphPad Prism
software, version 5 (GraphPad) and Stata, version 10 (Stata-
Corp). Distribution of variables was assessed by Shapiro-Wilk
and Shapiro-Francia tests. The v2 test was used to compare
proportions. Mann-WhitneyU andWilcoxon signed-rank tests
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were used for unmatched and matched comparisons, re-
spectively. Spearman rank test was used for correlations. The
relationships between cytokine concentrations and markers of
disease progression were evaluated using multivariate linear
regression. Variables were log-transformed, and cytokines were
standardized to allow for direct comparison of b-coefficients.
Mixed-effects logistic regression was used to assess the change
in HIV-1 shedding over time. P values ,.05 were considered
significant. P values were adjusted using false discovery rate
step-down procedure in order to reduce false-positive results
when multiple comparisons were made [27].
RESULTS
Forty-nine women recently infected with HIV-1 were recruited
and followed longitudinally. Their median age was 24 years
(range, 18–59). Most women (98%) were unmarried, 20% had
multiple partners, and 32% reported using injectable hormonal
contraceptives. The median CD41 T-cell count and viral load
measurements at 6 weeks postinfection were 524 cells/lL and
56 500 copies/mL, respectively (Table 1). The median CD41
T-cell loss during the first 12 months of HIV-1 infection was
486 cells/lL, while the median set-point viral load was 39 783
copies/mL. STIs and BV were prevalent in this cohort, both
pre– and post HIV-1 infection.
Cytokine Concentrations in the Genital Tract of Women Recently
Infected With HIV-1 Were Not Significantly Elevated Compared
With Preinfection
The concentrations of 22 cytokines in CVL from women
prior to HIV-1 infection (median, 36 weeks preinfection) were
compared with those of the same women during early HIV-1
infection (median, 6 weeks postinfection) for whom samples at
both time points were available (n 5 18). In matched samples,
TNF-a and eotaxin concentrations were higher in CVLs from
early HIV-1 infection compared with preinfection, whereas
MIP-3a concentrations were lower (P , .05; Figure 1A).
However, these changes were not significant after adjustment for
multiple comparisons. Furthermore, in an unmatched analysis
including all women who had either preinfection samples
(n 5 22) or 6-week postinfection samples available (n 5 39),
only MIP-3a concentrations were lower in postinfection CVLs,
before adjusting for multiple comparisons. These data indicate
that, in contrast to previous reports that have compared genital
cytokine concentrations in HIV-1 infected women to unmatched
HIV-uninfected women [10, 12–16], the women in this study
did not have significantly altered CVL cytokine concentrations
during early HIV-1 infection relative to preinfection samples
from women who later became infected with HIV-1.
Interestingly, the concentrations of 7 of 22 cytokines mea-
sured in CVLs correlated between pre– and postHIV-1 infection
(Figure 1B). MIP-1a and sCD40L remained significantly cor-
related after adjusting for multiple comparisons. Following
evaluation of cytokine concentrations in longitudinal samples
(17, 30, and 55 weeks postinfection), it was found that 11 of 20
cytokines correlated between at least 3 of the 5 time points. After
adjusting for multiple comparisons, IL-1a, IL-b, IL-6, IL-8,
MIP-1a, G-CSF, and GM-CSF were significantly correlated
across $3 time points. These findings suggest that the relative
degrees of cervicovaginal inflammation in individual women
remained relatively constant during the study period.
Table 1. Clinical Characteristics of Study Participants
CD41 T-Cell Counts (Cells/lL) Cells/lL, Median (IQR) No.
Preinfection CD41 T-cell count 975 (860–1149) 22
Six-week postinfection CD41 T-cell count 524 (379–685) 48
CD41 T-cell count set point (average of 3 visits overlying 12 months postinfection) 408 (339–551) 46
CD41 T-cell loss (preinfection minus 12-month postinfection CD41 T-cell count) 486 (254–653) 22
Plasma viral loads (copies/mL) Copies/mL, Median (IQR) No.
Six-week postinfection plasma viral load 56 500 (14 200–370 500) 49
Plasma viral load set point (average of 3 visits overlying 12-months postinfection) 39 783 (7248–102 208) 46




Prevalence of active STIs (women with laboratory-diagnosed STIa) 8/22 (36.3) 17/44 (38.6)
Bacterial vaginosis (women with Gram stain positive for BV) 15/22 (68.2) 34/44 (77.4)
Vaginal discharge (women with visible discharge) 3/22 (13.7) 8/49 (16.3)
Genital ulcer (women with visible genital ulcer[s]) 0/22 (0) 6/49 (12.2)




Participants with multiple transmitted variants 4/45 (8.9) 7/45 (15.6)
Abbreviations: BV, bacterial vaginosis; HIV-1, human immunodeficiency virus type 1; IQR, interquartile range; STI, sexually transmitted infection.
a Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, herpes simplex virus type 2.
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Genital Tract Inflammation During Early HIV-1 Infection Was Not
Associated With Multivariant HIV-1 Transmission
Abrahams et al [29] have reported that in this cohort of women,
22%were infected with.1 HIV-1 genetic variant. To investigate
the relationship between genital tract inflammation and trans-
mission of multiple HIV-1 variants, cytokine concentrations at
6 weeks postinfection were compared in women with multiple
(n5 10) or single (n5 25) transmitted variants. No differences
in cervicovaginal cytokines were found between women infected
with multiple or single variants (data not shown), suggesting
that genital inflammation was not associated with the break in
HIV-1 transmission bottleneck in this cohort.
Cervicovaginal Inflammation During Early HIV-1 Infection Was
Associated With STIs
Cytokine concentrations in CVL from women with early HIV-1
infection (6 weeks postinfection) who tested positive for$1 STI
or had symptoms of STIs were compared with those of women
who did not have an STI or BV (Figure 2). Women who had$1
active STI (C. trachomatis,N. gonorrhoeae, T. vaginalis, or HSV-2;
n 5 14) tended to have elevated cytokine concentrations;
however, these changes were not significant after adjusting for
multiple comparisons. Abnormal vaginal discharge, which may
be caused by other factors in addition to STIs, including BV,
Candida albicans, allergic reaction, irritation, or physiologic
changes [28], was associated with elevated concentrations of
proinflammatory IL-1a, IL-1b, IL-12p40, eotaxin, MIP-1a,
and T-cell homeostatic IL-15, after adjustment for multiple
comparisons.
Genital Tract Inflammation During HIV-1 Infection Was
Associated With HIV-1 Shedding
HIV-1 viral loads were measured in CVL samples collected at
6, 17, 30, and 55 weeks postinfection as an indicator of HIV-1
shedding. CVL viral loads and proportions of women with de-
tectable HIV-1 RNA did not differ significantly between time
points (Figure 3). CVL viral loads did not correlate between time
points, indicating that different women were shedding HIV-1 at
different times. Cytokine concentrations in CVL correlated with
CVL viral loads at all time points, and women who had de-
tectable HIV-1 RNA in their genital tracts had higher cytokine
concentrations than did women who were not shedding HIV-1
(Table 2). Preinfection cytokine concentrations did not differ
between women who were shedding and women who were not
shedding HIV-1 6 weeks postinfection. Additionally, lower
blood CD4 counts and/or higher plasma viral loads were asso-
ciated with CVL viral loads at each time point. The prevalence of
STIs did not differ between women with detectable HIV-1 RNA
levels in their genital tracts [3 of 7 (42.9%)] and women who
were not shedding [11 of 31 (35.5%)]. Furthermore, there were
no significant differences in occurrence of BV, vaginal discharge,
and genital ulcers in women shedding HIV-1 compared with
women who were not shedding.
Figure 1. Comparison of cervicovaginal lavage (CVL) cytokine concen-
trations in women (n5 18) before infection (median, 36 weeks preinfection)
and during early human immunodeficiency virus type 1 (HIV-1) infection
(median, 6 weeks postinfection). A, Fold changes in cytokine concentrations
following HIV-1 infection are shown as box-and-whisker plots; error bars
indicate the range. Wilcoxon signed-rank test was used to compare cytokine
concentrations in CVL from the same women pre– and post HIV-1-infection.
Changes in cytokine concentrations that were significant before adjusting for
multiple comparisons and are indicated by gray bars (P, .05). B, Spearman
correlations between cytokine concentrations measured in pre- and
postinfection CVL. MIP-1b was no longer correlated between time points
following exclusion of outliers. Gray dots indicate cytokines that correlated
significantly before adjusting for multiple comparisons (P, .05). Black dots
indicate cytokines that remained significantly correlated after adjustment
(P , .0023). G-CSF, granulocyte colony-stimulating factor; GM-CSF,
granulocyte macrophage-colony stimulating factor; IFN, interferon;
IL, interleukin; MCP, monocyte chemotactic protein; MIP, macrophage in-
flammatory protein; sCD40L, soluble CD40 ligand; TNF, tumor necrosis factor.
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Elevated Genital Tract Cytokine Concentrations During Early
HIV-1 Infection Correlated With Lower Blood CD41 T-Cell Counts
We have previously reported that cervicovaginal IL-1b, IL-6,
and IL-8 concentrations during early HIV-1 infection were as-
sociated with lower blood CD41 T-cell counts at these early time
points [15]. In this study, it was similarly found that higher
concentrations of IL-6 (q520.455, adjusted P5 .030), TNF-a
(q 5 20.498, adjusted P 5 .017), RANTES (q 5 20.460, ad-
justed P5 .026), and IL-10 (q520.503, adjusted P5 .027) in
CVL correlated with lower blood CD4 counts during early HIV-1
infection. Only weak associations between 17-, 30-, and 55-week
cytokine concentrations and concurrent CD4 cell counts were
found, and these were not significant after adjusting for multiple
comparisons, indicating that the relationship was restricted to
early HIV-1 infection.
Despite finding a significant correlation between (1) plasma
viral load and HIV-1 shedding and (2) genital inflammation and
HIV-1 shedding, few associations were found between genital
cytokine concentrations and plasma viral loads measured at the
same time points. This suggests that changes in inflammatory
cytokine production in the genital tract during early HIV-1
infection are largely independent of systemic viral load.
Cervicovaginal Inflammation During Early HIV-1 Infection Was
Associated With CD41 T-Cell Depletion During the First Year
of Infection
To determine whether genital cytokine concentrations during
HIV-1 infection were associated with disease progression, as-
sociations between cytokines and (1) average blood CD4 counts
measured at 3 consecutive visits overlying 12 months post-
infection and (2) CD4 loss between preinfection and 12 months
postinfection were investigated. Although higher concentrations
of several cytokines at multiple time points were associated with
lower CD4 counts 12 months postinfection before adjusting for
multiple comparisons, only GM-CSF concentrations 6 weeks
postinfection remained significantly associated after adjustment
(Figure 4A). No significant relationship between preinfection
cytokine concentrations and CD4 counts 12 months post-
infection was found, although relatively few CVL samples (22
of 49) from preinfection time points were available for this
analysis.
Blood CD4 counts and plasma viral loads during early HIV-1
infection were also associated with 12 month postinfection CD4
counts (b 5 .70 [95% CI, .46 to .95] and b 5 2.07 [95%Figure 2. Fold change in cytokine concentrations in cervicovaginal
lavage (CVL) samples from women who had $1 sexually transmitted
infection (STI) or bacterial vaginosis (BV) compared with the median
concentrations in women who did not have an STI. Cytokine concentrations
were measured in CVL samples from women infected with human
immunodeficiency virus type 1 (HIV-1) (median, 6 weeks postinfection)
who had no STI (n5 7), women who had visible vaginal discharge (n5 7)
or genital ulceration (n 5 4), women who had $1 laboratory-diagnosed
active STIs (Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas
vaginalis, or herpes simplex virus type 2 [HSV-2]; n5 14) and women who
Figure 2 continued. had BV (n 5 16). Mann-Whitney U test was used to
compare cytokine concentrations in CVL from women with STIs, BV, or
symptoms to women with no STIs and/or BV. Fold changes in cytokine
concentrations are shown as box-and-whisker plots; error bars indicate
the range. Gray bars indicate cytokines that were significantly different
before adjusting for multiple comparisons (P , .05). Stars indicate
cytokines that remained significant after adjustment (P , .0023).
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CI, –.12 to –.02], respectively). HIV-1 disease status could
predispose individuals to higher incidence of STIs and genital
shedding of HIV-1 [30, 31], thereby exacerbating genital in-
flammation, which would therefore be indirectly rather than
directly associated with disease progression. Multivariate re-
gression was thus used to adjust for CD4 counts and viral loads
measured at the same time points as cytokine concentrations.
Again, there was a strong trend toward an association between
higher cytokine concentrations and lower 12-month CD4 counts.
Finally, associations between preinfection (n5 22) and 6-week
postinfection (n 5 18) cytokine levels and blood CD41 T-cell
loss during the first 12 months of HIV-1 infection were in-
vestigated in a subset of women for whom preinfection CD4
count measurements were available. CD4 depletion during the
first year of infection was associated with higher preinfection
cervicovaginal concentrations of RANTES (q 5 0.46, P 5 .03)
and 6-week postinfection concentrations of IL-1b (q 5 0.53,
P 5 .02) and GM-CSF (q 5 0.62, P 5 .006). However, these
associations were not upheld after adjusting for multiple
comparisons, which may be due to the relatively small sample
sizes available for this analysis.
Genital Inflammation During Early HIV-1 Infection Was
Associated With Higher Viral Load Set Point
It was found that the concentrations of several inflammatory
and T-cell homeostatic cytokines in CVL during early HIV-1
infection (6 and 17 weeks postinfection) were associated with
higher plasma viral load set point (Figure 4B), even though these
cytokines did not correlate with viral loads measured at the same
time points as cytokine measurements. No associations between
cytokine concentrations at later time points postinfection
(30 and 55 weeks postinfection) and viral load set point were
significant after adjusting for multiple comparisons. Addi-
tionally, although cytokine concentrations did not differ be-
tween preinfection and early infection time points, no
significant associations between preinfection cytokine concen-
trations and viral load set point were found. Elevated GM-CSF,
IL-1b, IL-12p70, and IL-15 concentrations at 6 weeks post-
infection and GM-CSF, IL-1b, IL-10, IL-6, RANTES, MIP-
1b, and IL-2 concentrations 17 weeks postinfection were
associated with higher viral load set point. Following ad-
justment for CD4 counts and viral loads measured at the
same time points as cytokine measurements, elevated GM-
CSF concentrations 6 weeks postinfection remained signifi-
cantly associated with higher viral load set point. This suggests
that the relationship between this inflammatory cytokine and
disease progression is at least partly independent of early infection
systemic disease state.
DISCUSSION
Previous studies have shown that women with early and chronic
HIV-1 infection have elevated genital inflammatory cytokine
concentrations relative to unmatched HIV-uninfected women
[10, 12–16]. This study is the first to compare cytokine con-
centrations in cervicovaginal samples from the same women
preinfection and during early HIV-1 infection. It was found that
inflammatory cytokine levels preinfection were correlated with
those postinfection and in fact were not significantly elevated
shortly following HIV-1 infection (6 weeks postinfection).
However, genital cytokine concentrations were higher in women
who had vaginal discharge and in women who were shedding
HIV-1 in their genital secretions. In addition, cytokine
concentrations were elevated in women who had lower blood
Figure 3. Human immunodeficiency virus type (HIV-1) RNA concentrations in cervicovaginal lavage (CVL) at 6, 17, 30, and 55 weeks postinfection. A,
HIV-1 viral loads in CVL from each woman are indicated by gray dots. Lines connect RNA concentrations in CVL from the same women at different time
points. No significant Spearman correlations were found between HIV-1 RNA levels at each time point, indicating that different women were shedding at
each time point. B, Proportion of women who had detectable HIV-1 RNA at each time point. Mixed-effects logistic regression was used to determine
whether the proportion of women shedding HIV-1 at 17, 30, and 55 weeks postinfection differed relative to 6 weeks postinfection; eb indicates the
change in number of women shedding at each time point relative to 6 weeks postinfection (reference time point). No significant differences were found.
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CD41 T-cell counts 6 weeks postinfection [15]. Elevated cer-
vicovaginal cytokines during early HIV-1 infection (6 and
17 weeks postinfection) were associated with higher plasma
viral load set point, which is predictive of time to AIDS [26].
Additionally, higher GM-CSF concentrations 6 weeks post-
infection were associated with lower CD4 counts 12 months
postinfection.
When genital cytokine concentrations were compared in the
same women preinfection and at several time points during the
first year of HIV-1 infection, some women maintained higher
levels of genital inflammation over time, while others had
consistently low cytokine concentrations. STI prevalence did not
differ between pre– and postHIV-1 infection; thus, the cause of
sustained inflammation may be STI recurrence. Mitchell et al
[18] demonstrated that genital inflammatory cytokines were
not elevated in chronically HIV-1 infected women relative to
uninfected women but rather were associated with BV. The
higher frequency of STIs in HIV-1 infected women compared
with uninfected women [17] may account for previous findings
that genital inflammatory cytokines are higher in women with
early HIV-1 infection. It is possible that elevated genital in-
flammatory cytokine responses, similar to those reported
shortly after SIV infection of macaques [6], may have subsided
by 6 weeks postinfection. Alternatively, cervicovaginal in-
flammatory cytokine concentrations may increase over time
during HIV-1 infection and may thus be higher in chronically
infected women relative to those with early infection [12].
Genital HIV-1 RNA concentrations correlated not only with
higher levels of genital inflammation but also with lower blood
CD4 counts and higher plasma viral loads at the same time
points. Although these findings may suggest that high systemic
viral loads drive HIV-1 shedding, which in turn induces genital
Table 2. Spearman Rank Correlations Between CVL HIV-1 RNA Concentrations and Blood CD4 Counts, Plasma Viral Loads, and CVL
Cytokine Concentrations
6 Weeks Postinfection 17 Weeks Postinfection 30 Weeks Postinfection 55 Weeks Postinfection
q (P Value) q (P Value) q (P Value) q (P Value)
Blood CD41 T-cell count 20.485 (.002) 20.305 (.090) 20.428 (.007) 20.047 (.782)
Plasma viral load 0.430 (.006) 0.533 (.002) 0.314 (.055) 0.371 (.022)
IL-1a 0.236 (.147) 0.154 (.401) 0.260 (.114) 0.337 (.039)a
IL-1b 0.355 (.026)a 0.478 (.006)b 0.207 (.212) 0.513 (.001)b
IL-6 0.427 (.007)a 0.446 (.011)b 0.261 (.113) 0.338 (.038)a
IL-12p40 0.159 (.333) 0.211 (.247) 0.294 (.073) 0.175 (.293)
IL-12p70 0.325 (.044) 0.204 (.263) 0.177 (.287) 0.027 (.873)
TNF-a 0.388 (.015)a 0.382 (.031)a 0.415 (.010)a 0.309 (.059)
Eotaxin 0.216 (.186) 0.227 (.211) 20.038 (.821) 0.473 (.003)b
Fractalkine 0.163 (.321) 0.405 (.022)a 20.186 (.264) 0.331 (.042)a
IL-8 0.323 (.045) 0.279 (.122) 0.393 (.015)a 0.437 (.006)b
MCP-1 0.419 (.008)a 0.487 (.005)b 0.099 (.555) 0.432 (.007)b
MIP-1a 0.155 (.345) 0.385 (.030)a 0.059 (.726) 0.128 (.445)
MIP-1b 0.186 (.258) 0.570 (.001)b 0.087 (.604) 0.314 (.055)
RANTES 0.490 (.002)a 0.531 (.002)b 0.267 (.106) 0.549 (.0004)b
G-CSF 0.310 (.055) 0.457 (.009)b 0.198 (.234) 0.379 (.019)a
GM-CSF 0.090 (.585) 0.537 (.002)b 0.315 (.054) 0.077 (.645)
MIP-3a 0.226 (.207) ND ND ND
IFN-a 0.212 (.201) ND ND ND
IL-10 0.378 (.018)a 0.247 (.173) 0.038 (.821) 20.160 (.336)
IL-2 0.385 (.015)a 0.534 (.002)b 0.137 (.413) 20.134 (.421)
IL-7 0.260 (.110) 0.119 (.517) 0.126 (.450) 20.057 (.736)
IL-15 0.382 (.016)a 0.220 (.226) 0.375 (.020)a 20.013 (.939)
sCD40L 0.331 (.040)a 0.309 (.085) 0.218 (.188) 0.123 (.462)
Significant associations are shown in bold (P , .05). Associations that were significant after adjusting for multiple comparisons are underlined.
Abbreviations: CVL, cervicovaginal lavage; G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte macrophage colony-stimulating factor; HIV -1,
human immunodeficiency virus type 1; IFN, interferon; IL, interleukin; MCP, monocyte chemotactic protein; MIP, macrophage inflammatory protein; ND, not done;
sCD40L, soluble CD40 ligand; TNF, tumor necrosis factor.
a Cytokine concentration significantly higher in women who had detectable HIV-1 RNA in their genital tracts compared with women who had undetectable HIV-1
RNA concentrations (P , .05).
b Cytokine concentration significantly higher in women who had detectable HIV-1 RNA after adjusting for multiple comparisons.
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inflammation, which is thus indirectly associated with disease
progression, shedding during early HIV-1 infection was not
associated with 12-month CD4 counts or viral load set point.
Additionally, genital inflammation during early HIV-1
infection was only weakly associated with concurrent plasma
viral load before adjusting for multiple comparisons but was
strongly associated with plasma viral loads at subsequent time
points. It was also found that, although CVL cytokine levels
Figure 4. Linear regression was used to assess relationships between cytokine concentrations in cervicovaginal lavage (CVL) from women 6 weeks
(n 5 37) and 17 (n 5 31) weeks postinfection and average blood CD4 counts of 3 consecutive visits overlying the 12-month postinfection time point
(A ) and viral load set points (B ). Viral loads, CD4 counts, and cytokine concentrations were log-transformed, and cytokine concentrations were
standardized to allow for direct comparison between b-coefficients. b-Coefficients that were generated by univariate regression are indicated by circles
and show the relationship between each cytokine and 12-month CD4 counts or viral load set points. b-Coefficients that indicate the relationships
between cytokine concentrations and 12-month CD4 counts or viral load set points, following adjustment for CD4 counts and viral loads at the
same visits as cytokine measurements using multivariate regression, are represented by triangles. Error bars indicate 95% confidence intervals.
Cytokines were ranked according to the strength of their associations with 12-month CD4 counts or viral load set point. Significant associations
are shown in blue (P , .05). Associations that were significant after adjusting for multiple comparisons are shown in red. G-CSF, granulocyte
colony-stimulating factor; GM-CSF, granulocyte macrophage-colony stimulating factor; IFN, interferon; IL, interleukin; MCP, monocyte chemotactic
protein; MIP, macrophage inflammatory protein; sCD40L, soluble CD40 ligand; TNF, tumor necrosis factor.
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correlated positively over time, different women were shedding
at different time points during HIV-1 infection. Therefore,
shedding was not the cause of sustained cervicovaginal in-
flammation that was observed in this cohort, and genital in-
flammation may rather facilitate HIV-1 shedding in individuals
who have high plasma viral loads by recruiting HIV-1-infected
cells to the genital tract and by promoting viral replication.
It was found that elevated CVL cytokine concentrations
6 weeks postinfection were associated with lower blood CD4
counts at the same time point. Blood CD4 depletion may reflect
CD4 depletion in the genital tract. This would contribute to
genital inflammation by inducing T-cell homeostatic cytokine
production [32], which in turn induces inflammatory cytokine
production [33, 34]. In support, T-cell homeostatic cytokines
IL-2 and IL-15 were inversely associated with blood CD4 counts
before adjusting for multiple comparisons. Therefore, STIs and
other factors that are associated with vaginal discharge are likely
to be major contributors to cervicovaginal inflammation during
early HIV-1 infection, with inflammation exacerbated by HIV-1
replication in the genital tract and the homeostatic response to
CD4 depletion. A recent macaque study demonstrated the im-
portance of proinflammatory cytokine production in the genital
tract in establishment of productive SIV infection following
vaginal inoculation [4]. Wang et al [24] further showed that
induction of inflammatory cytokine responses in the genital
tracts of macaques prior to vaginal inoculation with SIV was
associated with increased plasma viral load set point, suggesting
that genital cytokine concentrations at the time of infection may
influence disease progression. Similar to macaque studies, it was
found in this study that higher levels of cervicovaginal proin-
flammatory and T-cell homeostatic cytokines during early HIV-1
infection were associated with more rapid HIV-1 disease pro-
gression. Additionally, the findings of this study suggest that
the association between genital inflammation during early in-
fection and disease progression is partly independent of blood
CD4 counts and plasma viral loads measured at the same time
points as cytokine concentrations. Although the earliest time
point included in this study (6 weeks postinfection) was past
viral dissemination to blood, preinfection genital cytokine
concentrations correlated with those measured during the
first year of HIV-1 infection. Therefore, genital inflammation
6 weeks postinfection may reflect inflammation at the time of
infection. Although preinfection genital inflammation may be
associated with HIV-1 disease progression, this could not be
investigated here as the number of women for whom pre-
infection samples were available was small (22 of 49 women).
Cytokine concentrations measured 6 weeks postinfection (range,
1–13) may, however, be a closer representation of the level of
genital inflammation present at the time of HIV-1 infection
than were preinfection cytokine concentrations that were mea-
sured 36 weeks prior to infection (range, 2–92). Higher concen-
trations of cervicovaginal inflammatory cytokines at the time of
HIV-1 transmission may favor disease progression by recruiting
and activating CD41 T cells for HIV-1 infection and directly
promoting viral replication [4, 9–11]. These findings suggest that
the inflammatory environment in the genital tracts of women who
become infected with HIV-1 through sexual transmission may
influence disease outcome and that strategies to reduce genital
inflammation may slow disease progression.
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1997; 11:F85–93.
32. Catalfamo M, Mascio MD, Hu Z, et al. HIV infection-associated im-
mune activation occurs by two distinct pathways that differentially affect
CD4 and CD8 T cells. Proc Natl Acad Sci U S A 2008; 105:19851–6.
33. AldersonMR, Tough TW, Ziegler SF, Grabstei KH. Interleukin 7 induces
cytokine secretion and tumoricidal activity by human peripheral blood
monocytes. J Exp Med 1991; 173:923–30.
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